Analgesic Efficacy and Safety of ADL5859 in Subjects With Acute Dental Pain After Third Molar Extraction

Conditions

• Acute Pain

Interventions

• DRUG: Placebo
• DRUG: ADL5859 30 mg
• DRUG: ADL5859 100 mg
• DRUG: ADL5859 200 mg
• DRUG: ibuprofen 400 mg

Sponsor

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)